PDIA3 and neoplasm: Furthermore, DCs are fully engaged by direct ligand–receptor contacts with tumor cells, such as the contacts between CRT/ERp57 and LDL receptor-related protein1/CD91 [6,7] or between HSP90 and TLR4 [11].